Exhibit 10.45


 


DATE: _____, 2022


 


	TO:	NeuroBo Pharmaceuticals, Inc. and
	 	Ladenburg Thalmann & Co. Inc.



  


To Whom It May Concern:


 


Reference is made to that
certain Underwriting Agreement, dated as of _____, 2022 (the “Underwriting Agreement”), between NeuroBo Pharmaceuticals, Inc.
(the “Company”) and Ladenburg Thalmann & Co. Inc., as representative of the underwriters named therein (the
 “Representative”) which provides for the execution and delivery of this voting agreement (“Voting Agreement”).
The Underwriting Agreement relates to the public offering of Company’s securities being conducted as set forth in the Company’s
registration statement on Form S-1 (Registration No. 333-267482). Capitalized terms used and not otherwise defined herein shall
have the meanings set forth in the Underwriting Agreement.


 


By signing this Voting Agreement,
the undersigned confirms and agrees that it shall vote all shares of the Company’s common stock, par value $0.001 per share (“Common
Stock”), over which the undersigned has voting control at such time in favor of any and all proposals and/or resolutions presented
by the Company to its stockholders at a meeting of stockholders to approve (i) the issuance of the underlying shares of Common Stock
upon exercise of the Warrants and (ii) additional proposals that may be required by the rules of the Nasdaq Capital Market (or
any successor entity) relating to the Warrants (referred to as the “Shareholder Approval” in the Underwriting Agreement).
The undersigned understands that the Company intends to hold a special meeting of stockholders as soon as practicable and that the Board
of Directors of the Company has established a record date of _____, 2022 for this special meeting (the “Record Date”).


 


This commitment and agreement
is being given by the undersigned at the request of the Company and shall remain in effect until the date and time Shareholder Approval
is obtained at a meeting of stockholders and effective.


 


This Voting Agreement is intended
for the exclusive benefit of the Company and the Representative and their respective successors and permitted assigns and is not for the
benefit of, nor may any provision hereof be enforced by, any other person or entity.


 


The obligations of the undersigned
under the terms and conditions of this Voting Agreement are several and not joint with the obligations of any other holder of any shares
of the Common Stock (each, an “Other Holder”), and the undersigned shall not be responsible in any way for the performance
of the obligations of any Other Holder under any such other agreement. Nothing contained in this Voting Agreement, and no action taken
by the undersigned pursuant hereto, shall be deemed to constitute the undersigned and Other Holders as a partnership, an association,
a joint venture or any other kind of entity, or create a presumption that the undersigned and the Other Holders are in any way acting
in concert or as a group with respect to such obligations or the transactions contemplated by this Voting Agreement and the Company acknowledges
that the undersigned and the Other Holders are not acting in concert or as a group with respect to such obligations or the transactions
contemplated by this Voting Agreement or any other agreement. The Company and the undersigned confirm that the undersigned has independently
participated in the negotiation of the transactions contemplated hereby with the advice of its own counsel and advisors. The undersigned
shall be entitled to independently protect and enforce its rights, including, without limitation, the rights arising out of this Voting
Agreement, and it shall not be necessary for any Other Holder to be joined as an additional party in any proceeding for such purpose.


 






    1


     


    

 


This Voting Agreement may
not be assigned by the Company without the written consent of the undersigned. No amendment or modification shall be made to this Voting
Agreement without the written consent of the undersigned.


 


This
Voting Agreement may be executed simultaneously in any number of counterparts. Each counterpart shall be deemed to be an original, and
all such counterparts shall constitute one and the same instrument. This Voting Agreement may be executed and accepted by PDF signature
and any such signature shall be of the same force and effect as an original signature.


 


Signatures
on the Following Page





 






    2


     


    

 





	 	By:	 
	 	
     

    

     
	Name of Stockholder: [_______________]

     

    Number of shares of Common Stock (and
    other voting shares) over which I have voting control as of the date hereof (which number may increase or decrease after the date hereof
    and prior to the record date of any such stockholder meeting): _________________



 


By signing below, the Company
agrees to the foregoing.


 


NEUROBO PHARMACEUTICALS, INC.


 


	By:	 	 
	Name:	 	 
	Title:	 	 



 


  


Signature
Page to 


the Voting
Agreement